AAAAAA
Results: 1-25/26
Authors:
Berard, A
Kahn, SR
Abenhaim, L
Citation: A. Berard et al., Is hormone replacement therapy protective for venous ulcer of the lower limbs?, PHARMA D S, 10(3), 2001, pp. 245-251
Authors:
Kurz, X
Lamping, DL
Kahn, SR
Baccaglini, U
Zuccarelli, FO
Spreafico, G
Abenhaim, L
Citation: X. Kurz et al., Do varicose veins affect quality of life? Results of an international population-based study, J VASC SURG, 34(4), 2001, pp. 641-648
Authors:
Shrier, I
Ehrmann-Feldman, D
Rossignol, M
Abenhaim, L
Citation: I. Shrier et al., Risk factors for development of lower limb pain in adolescents, J RHEUMATOL, 28(3), 2001, pp. 604-609
Authors:
van Staa, TP
Abenhaim, L
Cooper, C
Zhang, B
Leufkens, HGM
Citation: Tp. Van Staa et al., Public health impact of adverse bone effects of oral corticosteroids, BR J CL PH, 51(6), 2001, pp. 601-607
Authors:
Marrie, RA
Wolfson, C
Sturkenboom, MCJM
Gout, O
Heinzlef, O
Roullet, E
Abenhaim, L
Citation: Ra. Marrie et al., Multiple sclerosis and antecedent infections: A case-control study - Reply, NEUROLOGY, 56(2), 2001, pp. 283-283
Authors:
Loisel, P
Gosselin, L
Durand, P
Lemaire, J
Poitras, S
Abenhaim, L
Citation: P. Loisel et al., Implementation of a participatory ergonomics program in the rehabilitationof workers suffering from subacute back pain, APPL ERGON, 32(1), 2001, pp. 53-60
Authors:
Feldman, DE
Shrier, I
Rossignol, M
Abenhaim, L
Citation: De. Feldman et al., Risk factors for the development of low back pain in adolescence, AM J EPIDEM, 154(1), 2001, pp. 30-36
Authors:
van Staa, TP
Leufkens, HGM
Abenhaim, L
Zhang, B
Cooper, C
Citation: Tp. Van Staa et al., Oral corticosteroids and fracture risk: relationship to daily and cumulative doses, RHEUMATOLOG, 39(12), 2000, pp. 1383-1389
Authors:
van Staa, TP
Leufkens, HGM
Abenhaim, L
Begaud, B
Zhang, B
Cooper, C
Citation: Tp. Van Staa et al., Use of oral corticosteroids in the United Kingdom, QJM-MON J A, 93(2), 2000, pp. 105-111
Authors:
Van Staa, TP
Abenhaim, L
Cooper, C
Zhang, B
Leufkens, HGM
Citation: Tp. Van Staa et al., The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: Validation of study population and results, PHARMA D S, 9(5), 2000, pp. 359-366
Authors:
Kahn, SR
Solymoss, S
Lamping, DL
Abenhaim, L
Citation: Sr. Kahn et al., Long-term outcomes after deep vein thrombosis: Postphlebitic syndrome and quality of life, J GEN INT M, 15(6), 2000, pp. 425-429
Authors:
Van Staa, TP
Leufkens, HGM
Abenhaim, L
Zhang, B
Cooper, C
Citation: Tp. Van Staa et al., Use of oral corticosteroids and risk of fractures, J BONE MIN, 15(6), 2000, pp. 993-1000
Authors:
Abenhaim, L
Rossignol, M
Valat, JP
Nordin, M
Avouac, B
Blotman, F
Charlot, J
Dreiser, RL
Legrand, E
Rozenberg, S
Vautravers, P
Citation: L. Abenhaim et al., The role of activity in the therapeutic management of back pain - Report of the International Paris Task Force on Back Pain, SPINE, 25(4), 2000, pp. 1S-33S
Authors:
Rossignol, M
Abenhaim, L
Seguin, P
Neveu, A
Collet, JP
Ducruet, T
Shapiro, S
Citation: M. Rossignol et al., Coordination of primary health care for back pain - A randomized controlled trial, SPINE, 25(2), 2000, pp. 251-258
Authors:
Marrie, RA
Wolfson, C
Sturkenboom, MCJM
Gout, O
Heinzlef, O
Roullet, E
Abenhaim, L
Citation: Ra. Marrie et al., Multiple sclerosis and antecedent infections - A case-control study, NEUROLOGY, 54(12), 2000, pp. 2307-2310
Authors:
Rich, S
Rubin, L
Walker, AM
Schneeweiss, S
Abenhaim, L
Citation: S. Rich et al., Anorexigens and pulmonary hypertension in the United States - Results fromthe surveillance of North American pulmonary hypertension, CHEST, 117(3), 2000, pp. 870-874
Authors:
Abenhaim, L
Moore, N
Begaud, B
Citation: L. Abenhaim et al., The role of pharmacoepidemiology in pharmacovigilance: A conference at the6th ESOP Meeting, Budapest, 28 September 1998, PHARMA D S, 8, 1999, pp. S1-S7
Authors:
Feldman, D
Shrier, I
Rossignol, M
Abenhaim, L
Citation: D. Feldman et al., Adolescent growth is not associated with changes in flexibility, CLIN J SPOR, 9(1), 1999, pp. 24-29
Authors:
Kurz, X
Kahn, SR
Abenhaim, L
Clement, D
Norgren, L
Baccaglini, U
Berard, A
Cooke, JP
Cornu-Thenard, A
Depairon, M
Dormandy, JA
Durand-Zaleski, I
Fowkes, GR
Lamping, DL
Partsch, H
Scurr, JH
Zuccarelli, F
Citation: X. Kurz et al., Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis andmanagement - Summary of an evidence-based report of the VEINES task force, INT ANGIOL, 18(2), 1999, pp. 83-102
Authors:
Feldman, DE
Rossignol, M
Shrier, L
Abenhaim, L
Citation: De. Feldman et al., Smoking - A risk factor for development of low back pain in adolescents, SPINE, 24(23), 1999, pp. 2492-2496
Authors:
Kahn, SR
Joseph, L
Abenhaim, L
Leclerc, JR
Citation: Sr. Kahn et al., Clinical prediction of deep vein thrombosis in patients with leg symptoms, THROMB HAEM, 81(3), 1999, pp. 353-357
Authors:
Abenhaim, L
Humbert, M
Citation: L. Abenhaim et M. Humbert, Pulmonary hypertension related to drugs and toxins (vol 14, pg 437, 1999), CURR OPIN C, 14(6), 1999, pp. AR5-AR5
Authors:
Abenhaim, L
Humbert, M
Citation: L. Abenhaim et M. Humbert, Pulmonary hypertension related to drugs and toxins, CURR OPIN C, 14(5), 1999, pp. 437-441
Authors:
Abenhaim, L
Rich, S
Benichou, J
Begaud, B
Citation: L. Abenhaim et al., Primary pulmonary hypertension and anorectic drugs - Reply, N ENG J MED, 340(6), 1999, pp. 481-482
Authors:
Collet, JP
Sharpe, C
Belzile, E
Boivin, JF
Hanley, J
Abenhaim, L
Citation: Jp. Collet et al., Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing, BR J CANC, 81(1), 1999, pp. 62-68